U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C24H28FN3O2
Molecular Weight 409.4964
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MESPIPERONE

SMILES

CN1CN(C2=CC=CC=C2)C3(CCN(CCCC(=O)C4=CC=C(F)C=C4)CC3)C1=O

InChI

InChIKey=QHJLPOSPWKZACG-UHFFFAOYSA-N
InChI=1S/C24H28FN3O2/c1-26-18-28(21-6-3-2-4-7-21)24(23(26)30)13-16-27(17-14-24)15-5-8-22(29)19-9-11-20(25)12-10-19/h2-4,6-7,9-12H,5,8,13-18H2,1H3

HIDE SMILES / InChI

Molecular Formula C24H28FN3O2
Molecular Weight 409.4964
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

N-Methylspiperone (NMSP) is a derivate of spiperone and high-affinity D2/3 dopamine and 5-HT2A serotonin receptor antagonist. In the biodistribution studies in rodents, there was a high accumulation of radioactivity in the liver, lung, and kidneys, whereas the brain radioactivity was not as high N-Methylspiperone is used to study the dopamine and serotonin neurotransmitter systems. Labeled with the radioisotope carbon-11, it can be used for positron emission tomography (PET). [11C] N-Methylspiperone PET is useful for objective monitoring of D2and 5-HT2A receptor occupancy and density in patients being treated with antipsychotic drugs.

CNS Activity

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
0.133 nM [Ki]
0.265 nM [Ki]
0.55 nM [Ki]

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
Unknown

PubMed

Patents

Sample Use Guides

In Vivo Use Guide
11C-NMSP PET studies were taken 40 min after a bolus i.v. injection of approximately 20 mCi 11C-NMSP. To create the normal 11C-NMSP SPM image template, additional dynamic scans were obtained at 0–60 min after injection of 11C-NMSP under the resting state in healthy controls.
Route of Administration: Intravenous
In Vitro Use Guide
HEK293 cells stably expressing human dopamine D2 and D3 receptors were used for activity evaluation. Immediately prior to testing, N-Methylspiperone was freshly dissolved in 30% DMSO and 70% H2O to a stock concentration of 100 μM and diluted into 13 half-log serial dilutions using 30% DMSO vehicle. Final test concentrations ranged from 10 μM to 10 pM. Radioligand competition experiments were conducted in glass tubes containing 300 μL of fresh EBSS buffer with 0.2 mM sodium metabisulfite, 50 μL of diluted test compound, 100 μL of membranes (10 μg total protein). All compound dilutions were tested in triplicate and the reaction incubated for 1 h at room temperature. The reaction was terminated by filtration through Whatman GF/B filters, presoaked for 1 h in 0.5% polyethylenimine, using a Brandel R48 filtering manifold (Brandel Instruments, Gaithersburg, MD).
Substance Class Chemical
Record UNII
5U54JM2T8G
Record Status Validated (UNII)
Record Version